[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Bulletin du Cancer Année : 1998

[Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance].

P. Pourquier
  • Fonction : Auteur
Y Pommier
  • Fonction : Auteur

Résumé

DNA topoisomerases I are ubiquitous enzymes that play a crucial role in DNA condensation, replication, transcription, and repair. Eukaryotic enzymes are highly conserved and specifically targeted by natural anticancer agents such as camptothecin and its derivatives. These drugs poison top 1 by inhibiting the enzyme via trapping of top 1 clivage complexes, which ultimately generate cell death. New camptothecin derivatives with better pharmacologic characteristics are under development. Understanding top 1 functions and structure will help to discover more specific and less toxic top 1 inhibitors in order to circumvent drug resistance.
Fichier non déposé

Dates et versions

inserm-02438250 , version 1 (14-01-2020)

Identifiants

  • HAL Id : inserm-02438250 , version 1
  • PUBMED : 9932078

Citer

P. Pourquier, Y Pommier. [Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance].. Bulletin du Cancer, 1998, Spec No, pp.5-10. ⟨inserm-02438250⟩

Collections

INSERM
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More